Skip to main content
Clinical Trials/NL-OMON40378
NL-OMON40378
Completed
Not Applicable

The effects of body weight support, guidance, and gait speed on patterns of muscle activity in the Lokomat, in persons with post stroke hemiparesis and in healthy walkers - Patterning of muscle activity in the Lokomat in persons with stroke

niversitair Medisch Centrum Groningen0 sites20 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
cerebrovascular accident (CVA)
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
20
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. First ever, unilateral stroke (infarction or hemorrhage)
  • 2\. At least 3 months post onset
  • 3\. Unilateral paresis of the leg
  • 4\. A Functional Ambulation Categories Score of 2 (Patient needs continuous or intermittent support of one person to help with balance and coordination\*\*), 3 (\*Patient requires verbal supervision or stand\-by help from one person without physical contact\*), or 4 ('\*Person can walk independently on level ground, but requires help on stairs, slopes or
  • uneven surfaces\*).
  • 5\. Patient should be older than 18 years to be included

Exclusion Criteria

  • 1\. Severely impaired cognitive functions (Mini Mental State Exam score \<\=25\)
  • 2\. Severe speech, language or communication disorders (left to clinical judgment whether the patient is able to understand instructions and to provide informed consent; in case of doubt the Aachen Aphasia Test will be administered).
  • 3\. Insufficient working knowledge the Dutch language to understand instructions and provide informed consent (clinical judgment).
  • 4\. Severe visual problems (clinical judgment).
  • 5\. Severe neglect (clinical judgment through observation. In case of doubt, the Star Cancelation Test can be administered).
  • 6\. Co\-morbidity that can affect the results of the study (e.g. pre\-existent problems in leg function or a progressive neurological disorder).
  • 7\. Participation in other scientific studies.

Outcomes

Primary Outcomes

Not specified

Similar Trials